Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $25.0800 (4.5%) ($24.0700 - $25.1200) on Sat. May. 4, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.67% (three month average) | RSI | 47 | Latest Price | $25.0800(4.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.1% a day on average for past five trading days. | Weekly Trend | EDIT declines -3.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting EDIT price | EDIT will decline at least -1.835% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.835% (StdDev 3.67%) | Hourly BBV | 0 () | Intraday Trend | 3.6% | | | |
|
1 - 5 Day Possible Target | $16.39(-34.65%) | Resistance Level | $26.2 | 5 Day Moving Average | $24.66(1.7%) | 10 Day Moving Average | $25.83(-2.9%) | 20 Day Moving Average | $26.2(-4.27%) | To recent high | -9.7% | To recent low | 29.1% | Market Cap | $N/A | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |